Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-10-1
pubmed:abstractText
Acute intraperitoneal (i.p.) administration of cholecystokinin (CCK) is known to induce a significant, but short-lasting, reduction in food intake, followed by recovery within hours. Therefore, we had covalently coupled CCK to a 10 kDa polyethylene glycol and showed that this conjugate, PEG-CCK(9), produced a significantly longer anorectic effect than unmodified CCK(9). The present study assessed the dose-dependency of this response and the effect of two selective CCK(1) receptor antagonists, with different abilities to cross the blood-brain barrier (BBB), on PEG-CCK(9)-induced anorexia.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-10450335, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-10504030, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-10744903, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-11421586, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-11510630, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-11587488, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-12052709, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-12586206, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-12612647, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-12738611, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-12782222, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-15556362, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-15722054, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-16243265, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-16907, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-17379357, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-2321020, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-2326329, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-2891833, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-3349234, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-405385, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-6286044, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-6291099, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-7682135, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-8090818, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-8140164, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-8513125, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-8543917, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-8581271, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-9670215, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618299-9761380
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Appetite Depressants, http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Cholecystokinin, http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations, http://linkedlifedata.com/resource/pubmed/chemical/Devazepide, http://linkedlifedata.com/resource/pubmed/chemical/N-(2-naphthalenesulfonyl)aspartyl-(2..., http://linkedlifedata.com/resource/pubmed/chemical/Naphthalenesulfonates, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Cholecystokinin A, http://linkedlifedata.com/resource/pubmed/chemical/cholecystokinin 9
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
152
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
396-403
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:17618299-Animals, pubmed-meshheading:17618299-Anorexia, pubmed-meshheading:17618299-Appetite Depressants, pubmed-meshheading:17618299-Aspartic Acid, pubmed-meshheading:17618299-Blood-Brain Barrier, pubmed-meshheading:17618299-Cholecystokinin, pubmed-meshheading:17618299-Delayed-Action Preparations, pubmed-meshheading:17618299-Devazepide, pubmed-meshheading:17618299-Dose-Response Relationship, Drug, pubmed-meshheading:17618299-Eating, pubmed-meshheading:17618299-Injections, Intraperitoneal, pubmed-meshheading:17618299-Male, pubmed-meshheading:17618299-Naphthalenesulfonates, pubmed-meshheading:17618299-Peptide Fragments, pubmed-meshheading:17618299-Polyethylene Glycols, pubmed-meshheading:17618299-Rats, pubmed-meshheading:17618299-Rats, Wistar, pubmed-meshheading:17618299-Receptor, Cholecystokinin A, pubmed-meshheading:17618299-Satiation
pubmed:year
2007
pubmed:articleTitle
PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
pubmed:affiliation
Interdisciplinary Research Center, Katholieke Universiteit Leuven, Kortrijk, Belgium.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't